会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 미생물 유래 신규한 화합물 및 그 화합물의 항암제로서의 용도
    • 微生物的新型化合物及其作为抗癌药物的用途
    • KR1020110043245A
    • 2011-04-27
    • KR1020090100279
    • 2009-10-21
    • 건국대학교 산학협력단
    • 정유훈임융호이영한신순영구본성우윤경윤상홍김미경
    • C07D487/04C07D487/02A61K31/437A61P35/00
    • PURPOSE: A microorganism-derived novel compound and a use of the compound as an anticancer agent are provided to enhance p53 and p21 protein expression and to suppress cyclin D1 expression. CONSTITUTION: A microorganism-derived novel compound is denoted by formula, 10HEA-F3. The compound is derived from microorganism. The composition enhances expression level of p53 and p21 in cancer cells. The microorganism is Burkholderia sp.(deposit number KACC 91391P). A pharmaceutical composition for anticancer contains a compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. A method for preparing the compound of chemical formula 1 comprises: a step of culturing Burkholderia sp.; a step of treating an organic solvent to the culture medium for extraction; and a step of performing chromatography to obtain an active fraction.
    • 目的:提供一种微生物衍生的新化合物和该化合物作为抗癌剂的用途,以增强p53和p21蛋白的表达并抑制细胞周期蛋白D1的表达。 构成:由微生物衍生的新化合物由式10HEA-F3表示。 该化合物来源于微生物。 该组合物增强癌细胞中p53和p21的表达水平。 微生物是伯克霍尔德氏菌属(BKKC 91391P)。 抗癌用药物组合物含有化学式1的化合物或其药学上可接受的盐作为有效成分。 制备化学式1的化合物的方法包括:培养伯克霍尔德氏菌的步骤; 将有机溶剂处理至培养基进行萃取的步骤; 以及进行色谱以获得活性部分的步骤。
    • 4. 发明公开
    • 비스에틸헥실프탈레이트의 항암제로서의 용도
    • 使用双 - (2-乙基己基)邻苯二甲酸酯的抗癌剂
    • KR1020100009364A
    • 2010-01-27
    • KR1020080070216
    • 2008-07-18
    • 건국대학교 산학협력단
    • 안중훈임융호정유훈홍성원이영한신순영용연중강경래구본성윤상홍여윤수김수진이창묵이미혜
    • A61K31/194A61P35/00
    • PURPOSE: A pharmaceutical composition containing bis-(2-ethylhexyl) phthalate for anti-cancer is provided to suppress activation of Akt protein in cancer cells and suppress cancer cell proliferation. CONSTITUTION: An anti-cancer composition contains bis-(2-ethylhexyl) phthalate of chemical formula 1. The composition suppresses cancer cell proliferation and induces apoptosis. The bis-(2-ethylhexyl) phthalate is isolated from Aeromonas hydrophila. A method for isolating bis-(2-ethylhexyl) phthalate comprises: a step of extracting Aeromonas hydrophila culture medium using solvent; a step of filtering and concentrating; and a step of isolating through chromatography. The solvent is alcohol including methanol, ethanol, isopropanol, and ethyleneglycol, and halogen-substituted hydrocarbon including methylene chloride, chloroform, and carbon tetrachloride.
    • 目的:提供含有邻苯二甲酸二(2-乙基己基)酯抗癌药物组合物,以抑制癌细胞中Akt蛋白的活化,抑制癌细胞增殖。 构成:抗癌组合物含有化学式1的邻苯二甲酸二(2-乙基己基)酯。该组合物抑制癌细胞增殖并诱导细胞凋亡。 邻苯二甲酸双(2-乙基己基)酯由嗜水气单胞菌分离。 一种分离邻苯二甲酸双(2-乙基己基)酯的方法,包括:使用溶剂萃取嗜水气单胞菌培养液的步骤; 过滤和集中的一个步骤; 和通过色谱分离的步骤。 溶剂是包括甲醇,乙醇,异丙醇和乙二醇的醇,以及包括二氯甲烷,氯仿和四氯化碳的卤素取代的烃。